New anti-malarial for all ages

YOU NOW HAVE THE CHOICE with PYRAMAX

Anti-malarial PYRAMAX 180mg/60mg tablet
60mg/20mg Granules for oral suspension
(Pyronaridinetetraphosphate/Artesunate)

Our Collaborations

Since 2002, Shin Poong Pharmaceutical & Medicines for Malaria Venture (MMV)° have been working
as partners to develop and provide access to PYRAMAX®.

°MMV researches and delivers new effective and affordable antimalarial to give populations
at risk of malaria a better chance of a healthy and prosperous future

• 
• "PYRAMAX® presents an excellent addition to current ACTs," said Prof. Abdoulaye Djimde, WANECAM Project Coordinator at MRTC, Bamako, Mali. "Not only can it be administered to patients of all ages from infants to adults, but it is easy to take, the patient requires no further treatment in 28 days, and it can be given again to patients who suffer from repeated bouts of malaria. PYRAMAX® will be a most welcome additional weapon for our fight against malaria"

• 

• NAME OF THE MEDICINAL PRODUCT:
  60 mg/20 mg Granules for oral suspension(Pyronaridinetetraphosphate and Artesunate)
  Summary of product characteristics
  ⇑ Click for downloading the file

  Indication: Pyramax Granules for oral suspension are indicated in the treatment of acute, uncomplicated malaria infection caused by Plasmodium falciparum or byPlasmodium vivax in children and infants weighing 5kg to under 20kg.

• 

• NAME OF THE MEDICINAL PRODUCT:
  180 mg/60 mg Tablet (Pyronaridinetetraphosphate and Artesunate)
  Summary of product characteristics
  ⇑ Click for downloading the file

  Indication: Pyramax tablets are indicated in the treatment of acute, uncomplicated malaria infection caused by Plasmodium falciparum or by Plasmodium vivax in adults and children weighing 20 kg or more.